Topic

Prostate Cancer

Fillmore has conducted extensive research to optimize the management of prostate cancer through precision oncology, comparative effectiveness studies of systemic therapies, and the identification of cancer-related comorbidities. His work includes the development of machine learning tools and protein panels to predict cardiovascular risk and venous thromboembolism, as well as the use of natural language processing to standardize clinical data extraction. Additionally, he has evaluated the efficacy of docetaxel rechallenge and compared the outcomes of abiraterone and enzalutamide in both castration-sensitive and castration-resistant disease.

Publications (10)

2026
2026
2026
2025
2023
2023